Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
P-glycoprotein (P-gp)
100%
Estramustine
100%
SKOV3
31%
Vinblastine
25%
Messenger RNA (mRNA)
12%
Estradiol
12%
Paclitaxel
12%
Multidrug-resistant
12%
Verapamil
12%
DU145
12%
Photoaffinity
12%
MDR1 Gene
12%
Drug Combination
12%
High Concentration
6%
Concentration-dependent
6%
Overexpression
6%
Progesterone
6%
Ethyl
6%
Prostate Cancer
6%
Cytotoxicity
6%
Laboratory Techniques
6%
Phase I Study
6%
Competitive Inhibition
6%
Membrane Protein
6%
Antitumor Activity
6%
Carbamate
6%
Membrane Fraction
6%
Southern Blot Analysis
6%
Human Cell Lines
6%
Azido
6%
Prostate Carcinoma
6%
Actinomycin D
6%
Gene Level
6%
Intracellular Drug Concentration
6%
Resistant Cell Lines
6%
Efflux Pump
6%
Drug Induction
6%
Human Prostate
6%
Estriol
6%
Microtubule-targeting Drugs
6%
Drug Cytotoxicity
6%
PGY1
6%
Clinical Protocols
6%
Drug Accumulation
6%
Estramustine Phosphate
6%
Chemosensitization
6%
Taxol/paclitaxel
6%
Pharmacology, Toxicology and Pharmaceutical Science
P-Glycoprotein
100%
Estramustine
100%
Paclitaxel
25%
Vinblastine
25%
Iodine-125
18%
Multidrug Resistance Protein 1
18%
Verapamil
12%
Diethylstilbestrol
12%
Combination Drug
12%
Messenger RNA
12%
Cytotoxicity
12%
Malignant Neoplasm
6%
Clinical Study
6%
Prostate Cancer
6%
Preclinical Study
6%
Membrane Protein
6%
Antitumor Activity
6%
Effusion
6%
Progesterone
6%
Dactinomycin
6%
Drug Concentration
6%
Estriol
6%
Estramustine Phosphate
6%
Carbamic Acid
6%
Prostate Carcinoma
6%